Roche: Julie Brown

Roche announced that Julie Brown will be stepping down as a member of the board of directors, effective immediately, after accepting the CFO role at pharmaceutical company GSK, starting in May. Brown was elected to the board in March 2016 and has been the chairwoman of the audit committee since then. Patrick Frost will be the interim chair of the committee until the general meeting in March 2023. 

Brown currently serves as chief operating and financial officer at fashion firm Burberry. She was previously group CFO at medical technology company Smith and Nephew. Brown also held multiple roles at AstraZeneca, including interim group CFO and VP of group finance, regional commercial VP of Latin America, and VP of corporate strategy.